Context Therapeutics® to Present Clinical Data on ONA-XR in Breast Cancer at 2021 San Antonio Breast Cancer Symposium

NEXT STORY
The Global Human Combination Vaccines Market is expected to grow by $ 7.16 bn during 2021-2025, progressing at a CAGR of almost 9% during the forecast period
PREV STORY
22nd Century Group Announces CFO Transition
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBI Vaccines Responds to Unfounded Allegations in Globes Article

CAMBRIDGE, Mass., Sept. 16, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”, ...

author_avatar
NASDAQ Market News

VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine

author_avatar
NASDAQ Market News

AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

author_avatar
NASDAQ Market News